Home » Hepatitis B » Page 2
Tag:

Hepatitis B

Health

Cuba Eliminates Pediatric Hepatitis B – A Global Success Story

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Cuba Leads Global Effort in Pediatric Hepatitis B Control and Elimination

cuba is being recognized globally for its significant success in controlling and potentially eliminating hepatitis B among children. The World Health Organization (WHO) has acknowledged the nation’s achievements in preventing mother-to-child transmission of the virus.

The heberbiovac HB vaccine, developed by the Center for Genetic Engineering and Biotechnology, has been instrumental in this effort. Since its implementation in 1999, Cuba has seen a dramatic reduction in pediatric hepatitis B cases.

This recombinant vaccine has demonstrated high immunogenicity and efficiency. It has been prequalified by the WHO and integrated into Cuba’s National Immunization Program since 1992.

The impact is clear: no hepatitis B cases were reported in children under five years old in 1999, with only one case recorded that year. This success story continues to the present day.

Furthermore, among children under 15, only a single diagnosis of hepatitis B occurred in 2022. this low incidence rate has been maintained since 2006, underscoring the effectiveness of systematic vaccination from birth.

0 comments
0 FacebookTwitterPinterestEmail
Health

State sees a fall in seroprevalence of Hepatitis B, says nodal officer

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Andhra Pradesh Hepatitis B Rates Decline Amidst Increased Screening

State Focuses on Awareness to Further Reduce Prevalence

Andhra Pradesh has achieved a reduction in Hepatitis B seroprevalence, dropping from 2.39% in 2021 to 1.8% in 2024. The state government is prioritizing public awareness campaigns to further curb the liver infection’s spread.

Hepatitis B More Prevalent in the State

Dr. S. Neelima, State Nodal Officer for the National Viral Hepatitis Control Programme, highlighted that Hepatitis B remains the most common of the five hepatitis viruses (A, B, C, D, and E) affecting the region. World Hepatitis Day, observed on July 28, serves as a crucial reminder to address this public health concern.

Extensive Screening Identifies Positive Cases

Between 2020 and the present, over 63.8 lakh individuals in Andhra Pradesh have been screened for Hepatitis B. Of these, more than 46,000 tested positive, with 6,750 individuals receiving treatment during the same period.

Significant Drop in Seroprevalence

A 2021 report indicated that Andhra Pradesh and Telangana shared the highest Hepatitis B prevalence at 2.39%, exceeding the national average of 0.95%. Dr. Neelima noted that the current 1.8% rate in 2024 reflects a positive trend, partly attributed to the government’s intensified screening efforts.

“While the rate decreased to 1.8% in 2024, more cases are getting detected in the State these days as the government has increased screening tests for people.”

—Dr. S. Neelima, State Nodal Officer for the National Viral Hepatitis Control Programme

The same 2021 report identified Hepatitis C seroprevalence in Andhra Pradesh and Telangana at 0.44%, surpassing the national rate of 0.32%. From 2020 to 2025, over 5,000 people are expected to have received treatment for Hepatitis C.

Understanding Transmission and Prevention

Dr. Neelima explained that Hepatitis A and E are transmitted through contaminated food and water. Hepatitis B and C spread via infected bodily fluids, unsafe sexual practices, and can pass from mother to child. Contaminated needles are another transmission route. Consequently, awareness campaigns are being conducted in places like saloons and tattoo studios.

While a vaccine is available for Hepatitis B, administered at birth, no vaccine exists for Hepatitis C, which is considered more dangerous. However, effective cures are available for Hepatitis C patients.

Mandatory Screening Protects Public Health

Given that these viral infections are often asymptomatic, individuals can unknowingly carry the viruses. To mitigate risk, mandatory screening for Hepatitis B and C is conducted before any surgical procedure or blood transfusion. Pregnant women are also routinely tested.

High-risk groups identified include sex workers, individuals who use drugs, and those who get tattoos. The state government has made testing free and accessible at all government hospitals, establishing 31 treatment centers across Andhra Pradesh.

Globally, an estimated 296 million people lived with chronic Hepatitis B infection in 2022, according to the World Health Organization (WHO). This underscores the importance of ongoing prevention and treatment efforts in regions like Andhra Pradesh.

0 comments
0 FacebookTwitterPinterestEmail
Health

World Hepatitis Day: Prevention, Treatment, and Global Challenges

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Hear’s a breakdown of the provided text, focusing on the key points about hepatitis B and C, and the perspective from Burela hospital:

Hepatitis B:

vaccine Availability: Spain has had the hepatitis B vaccine for over 30 years.
 Initially administered to risk groups.
Recommended for adolescents and newborns since 1992.
 Administered to newborns or young infants in all autonomous communities by 2002.
Vaccination Rates: Spain boasts “over 97%” vaccination rates for hepatitis B, which are described as the highest in the world (global average is 45%). This is considered a “Rotundo success.”
 Current Cases: the remaining cases in Spain are primarily “imported” from individuals from countries where the vaccine is not administered, especially from Africa.
Management of Imported Cases:
 These individuals cannot be vaccinated as they are already infected.
Effective treatments are available.
 The priority is to locate them to prevent community transmission. Burela’s Situation: Burela is a multicultural town with a “relatively high” incidence of hepatitis B among its emigrant population, but the problem is “controlled.”

Hepatitis C:

Key Difference: Hepatitis C, first identified in 1989, is distinct because there is no vaccine for it.
Disease Progression:
 90% of infected patients are asymptomatic.
Without treatment, the disease becomes chronic, leading to cirrhosis and liver cancer.
 Treatment Advancements:
A significant turning point occurred in 2011 with the introduction of direct-acting antivirals (DAAs).
 these treatments, lasting 8-12 weeks, achieve 98% healing rates.
Galicia‘s Progress:
 Since 2015, Galicia has had access to DAAs that cure patients in 2-3 months.
Screening Initiatives in Galicia:
 as 2023,people born between 1954 and 1983 are offered an additional test for hepatitis C when they visit primary care for analytics.
screening is also programmed during first-quarter pregnancy controls.
 The at-risk population is offered screening thru the Mobile HIV prevention unit.
reception and Results of Screening:
 The initiative has been “very well received,” with no one refusing the test.
Currently, only 3-5 positive cases are detected per year.
 These cases are caught in early stages, treated, and cured.
Goal of Screening: The aspiring goal is the eradication of hepatitis C.
 The WHO aims for eradication by 2030.
Spain hopes to achieve it sooner, though eradications are challenging.
 Smallpox is cited as an exmaple of eradication, which took a century after vaccination began.
* Egypt as an example: Egypt, once having the highest global prevalence of hepatitis C, conducted an ambitious WHO eradication campaign (2014-2020) where 50 million people were examined and over 4 million treated, achieving success.

Overall perspective from Burela Hospital (Dr. Carreira):

The hospital shares the WHO’s concerns but highlights the different contexts between developed and developing countries. They emphasize Spain’s success in hepatitis B vaccination and the significant progress made in treating hepatitis C with new antivirals and proactive screening. The ultimate goal is the eradication of hepatitis C, with Spain aiming to achieve this even before the WHO’s 2030 target.

0 comments
0 FacebookTwitterPinterestEmail
Docs emphasize Hepatitis B vaccine to stop liver most cancers – ANTARA Information Megapolitan
Health

Docs emphasize Hepatitis B vaccine to stop liver most cancers – ANTARA Information Megapolitan

by Chief editor of world-today-news.com
written by Chief editor of world-today-news.com
Head of Hepatobiliary Division, Division of Inside Medication, College of Medication, College of Indonesia, Cipto Mangunkusumo Hospital (RSCM) Dr. Dr. Dr. Rino Alvani Gani, SpPD-KGEH, FINASIM emphasised the necessity for Hepatitis B vaccine as a technique to stop liver illness.

“Major prevention is finished with Hepatitis B vaccine which has been confirmed to scale back the incidence of liver most cancers,” stated Rino within the ‘Liver Most cancers Protected Webinar’ performed in Jakarta on Saturday.

Rino stated the Hepatitis B vaccine reduces an individual’s threat of creating liver illness as proven by analysis from the Eighties to the early Nineties, the place the variety of individuals affected by liver most cancers was lower from 12 months to 12 months.

He stated that the Hepatitis B vaccine is at present given to new infants to stop the chance of liver most cancers.

As well as, pregnant girls who’re recognized as Hepatitis B constructive are additionally handled to scale back the opportunity of passing it on to their newborns.

As well as, routine ultrasound (USG) should be carried out frequently each six months.

The professor on the College of Medication, College of Indonesia, stated that persons are additionally suggested to not eat meals or drinks that comprise alcohol in the long run to keep up their well being.

“It could appear to be an issue, however it’s clear that this offers higher advantages than if liver most cancers had occurred,” he stated.

Rino appealed to individuals who have suffered from Hepatitis B, Hepatitis C, or others within the extreme class to be prepared to endure common ultrasounds in order that the chance of liver most cancers will be diminished.

In accordance with him, early detection is essential in curing liver most cancers as a result of there are a number of sufferers who arrive in a foul situation already and want superior therapy efforts.

He confirmed that liver most cancers is carefully linked to an infection with the Hepatitis B virus and Hepatitis C virus, though there are additionally circumstances discovered with out an infection with these viruses.

“Remedy continues to be tough and costly. Due to this fact, it’s potential to stop vaccination and wholesome residing habits, keep physique weight and train in order that metabolism stays good,” he stated.

2024-05-19 13:47:32
#Docs #emphasize #Hepatitis #vaccine #stop #liver #most cancers #ANTARA #Information #Megapolitan

0 comments
0 FacebookTwitterPinterestEmail
Chronic Hepatitis B Cases Surge in New York City, Majority in Men and Poor Neighborhoods
News

Chronic Hepatitis B Cases Surge in New York City, Majority in Men and Poor Neighborhoods

by Chief editor of world-today-news.com
written by Chief editor of world-today-news.com

New York.- Chronic hepatitis B increased in New York City in 2022 with 5,534 new cases, 174 more than in 2021 and most of them among men and poor neighborhoods, according to a report published this Wednesday by the Department of Health.

This is why state authorities seek to eradicate viral hepatitis as a public threat by 2030.

The “Hepatitis A, B and C in New York” report for 2022 adds that there were 2,805 new cases of chronic hepatitis C (which persists for more than six months), 27 less than in 2021. Hepatitis A cases, in turn, decreased by almost 50% in one year.

According to the study, cases of chronic hepatitis B had decreased since 2016 in the city. In 2020, the lowest number was recorded, with 4,002, but due to fewer people accessing health care services during the pandemic there was an increase in 2022.

It also highlights that inequalities persist by gender, age and neighborhood poverty level in new cases of hepatitis B and C.

Among people newly diagnosed with chronic hepatitis B in 2022, 58% were men, 49% were between 30 and 49 years old, 37% were from Brooklyn, 27% were from Queens, and 40% lived in high or very high poverty neighborhoods.

drug use

In the case of chronic hepatitis C, 64% were men, 34% were between 20 and 39 years old, 31% were from Brooklyn, 25% were from the Bronx, and 39% lived in high or very high poverty neighborhoods. Infections among young people are more likely due to recent exposure from sharing drug use instruments, the health agency said.

“While our most recent hepatitis A, B and C surveillance data reflect progress in some areas, it is clear that we have more work to do, especially to address the stark inequalities we continue to see,” Sarah Braunstein, Ph.D., said in the statement. deputy commissioner of the Office of Hepatitis, HIV and Sexually Transmitted Infections.

Compared to other infectious diseases, the fight against hepatitis remains “severely underfunded,” he stressed.

“Increased investment to expand and develop the capacity of our hepatitis workforce, Shoring up our surveillance infrastructure and supporting patient navigation programs are critical to achieving the goals of the city’s viral hepatitis elimination plan.“, he claimed.

The Health report includes updates on its plan together with community groups to eliminate hepatitis A, B and C as a public health threat by 2030, strategies to reduce new hepatitis B and C infections, improve the health of carriers and reduce health inequalities related to this infection.

Keep reading:

2024-01-05 02:31:00
#Hepatitis #cases #increase #York #poor #neighborhoods #Diario

0 comments
0 FacebookTwitterPinterestEmail
Understanding the HBsAg Test: Importance, Results, and Explanation of Hepatitis B
Health

Understanding the HBsAg Test: Importance, Results, and Explanation of Hepatitis B

by Chief editor of world-today-news.com
written by Chief editor of world-today-news.com

Jakarta –

HBsAg is an abbreviation of Hepatitis B Surface Antigen (hepatitis B surface antigen). This is a protein that appears in the blood when a person is infected with hepatitis B.

To find out whether someone has hepatitis B or not, an HBsAg test can be done. However, what is the HBsAg test? Check out the information in the following description.

What is the HBsAg Test?

Reported by the Verywell Health website, the HBsAg test is a blood test that detects the hepatitis B surface antigen. High HBsAg levels can usually indicate whether the hepatitis B virus (HBV) infection is active or not in the body.

HBsAg is the outer layer of HBV cells. The center of the cell contains viral DNA, while around it there is a protein called hepatitis B core antigen (HBcAg).

HBsAg surrounds HBcAg and becomes a hidden component that protects the virus from attack by the body’s natural immune system. But, the body’s immune system works to penetrate these components to kill the virus.

When the immune system succeeds in destroying the virus, there will be remnants of HBsAg left behind in debris such as blood. And this is what laboratory tests can detect.

Hepatitis B is an infection of the liver caused by the hepatitis B virus. The virus can spread when you come into contact with the blood, wounds or body fluids of someone who has hepatitis B.

In some people, hepatitis B can be mild and only last for a short time. Short-term (acute) cases of hepatitis B can become chronic and can cause liver failure, cancer and life-threatening conditions.

Hepatitis B is a serious disease. However, people with acute hepatitis B do not always experience symptoms. If you experience symptoms, they may include jaundice, light colored stools, fever, prolonged fatigue, stomach and joint pain.

Symptoms of chronic infections also do not always appear. If it appears, the symptoms will likely be the same as those of an acute case. And symptoms don’t appear 1-6 months after contracting HBV, so you may not feel anything if you get this disease.

According to the WebMD page, about a third of people who have hepatitis B do not feel that they have this disease. They only found out they were infected with hepatitis B through this HBsAg test.

Who Should Have an HBsAg Test?

Everyone can have an HBsAg test periodically or at least once in their life. However, you can take this test if you experience symptoms of hepatitis B which include:

Jaundice, such as the skin, whites of the eyes, and urine turning yellow, brown, or orange

Pale stools Fever Fatigue that lasts a long time Stomach disorders such as loss of appetite, nausea and vomiting Abdominal and joint pain.

In addition, HBsAg testing can be carried out routinely during pregnancy, before donating blood or organs, before starting immunosuppressive therapy, and in individuals who are at higher risk of contracting HBV.

By carrying out this test, a person will be identified whether they have acute or chronic hepatitis B. So they can also get hepatitis B vaccination afterwards.

Explanation of HBsAg Test Results

After doing the HBsAg test, you will get a positive or negative result. The following is an explanation of the results:

1. Positive HBsAg results

If the test results show positive then you are likely infected with hepatitis B. Not only that, you can find out whether you have acute or chronic hepatitis B. A positive HBsAg test result can also indicate that you can transmit the virus to other people.

However, it is said that the hepatitis B vaccine can also cause positive HBsAg test results, you know. Therefore, if you have just received a dose of hepatitis B vaccine, your doctor may recommend waiting another month to do the HBsAg test again.

2. Negative HBsAg results

If the HBsAg test result is negative, it means that the hepatitis virus surface antigen was not found in your blood sample. This also shows that you are not infected with hepatitis B.

Other Tests for Diagnosis of Hepatitis B

Apart from the HBsAg test, there are also several other tests that are carried out together to identify whether there is HBV infection in the body or not. Here are some other tests for the diagnosis of hepatitis B:

1. Tes Anti-HBs

The anti-HBs test or Hepatitis B Surface Antibody (hepatitis B surface antibody) is a test that shows immunity from HBV infection, either due to recovery after infection or from vaccination.

2. Tes Anti-HBc

The anti-HBc test or Total Antibody to Hepatitis B core Antigen (total antibody to hepatitis B core antigen) is a test that measures antibodies and shows whether you have ever had an active HBV infection. Anti-HBc appears early in HBV infection and can persist for life.

3. Tes IgM Anti-HBc

The IgM Antibody to Hepatitis B core Antigen test (IgM antibody to hepatitis B core antigen) is a test that shows whether acute HBV infection has occurred within the last 6 months or not.

That was an explanation of the HBsAg test to detect hepatitis B. So, have you done this test and other hepatitis B tests, detikers?

Watch the video “Ministry of Health’s Efforts to Overcome Transmission of Hepatitis B from Mother to Child”

(inf/inf)

2023-11-05 00:01:19
#HBsAg #Test #Detecting #Hepatitis

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com